as on November 8, 2025 at 2:29 am IST
Day's Low
Day's High
2.77%
Downside
1.30%
Upside
52 Week's Low
52 Week's High
18.80%
Downside
30.23%
Upside
Check Harmony Biosciences Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.8B
EPS (TTM)
4.0364
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.10%
PE Ratio (TTM)
9.76
Industry PE ratio
8.355964912280701
PEG Ratio
0EBITDA
249.5M
Revenue (TTM)
825.9M
Profit Margin
22.48%
Return On Equity TTM
25.93%
Track how Harmony Biosciences Holdings Inc P/E has moved over time to understand its valuation trends.
Harmony Biosciences Holdings Inc in the last 5 years
Lowest (-14.38x)
March 31, 2021
Industry (8.36x)
November 8, 2025
Today (9.76x)
November 8, 2025
Highest (48.02x)
December 31, 2021
Today’s Price to Earnings Ratio: 9.76x
Compare market cap, revenue, PE, and other key metrics of Harmony Biosciences Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.8B | -31.15% | 9.76 | 22.48% | |
| BUY | $40.5B | 482.44% | -16.34 | -264.83% | |
| BUY | $58.2B | 238.64% | 1420.94 | 1.36% | |
| BUY | $105.6B | 85.89% | 29.33 | 31.35% | |
| BUY | $68.0B | 13.75% | 15.51 | 32.13% |
The Harmony Biosciences Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Harmony Biosciences Holdings Inc investment value today
Current value as on today
₹92,259
Returns
Returns from Harmony Biosciences Holdings Inc Stock
Dollar Returns*
₹5,147 (+5.15%)
Based on 14 analysts
78.57%
Buy
7.14%
Hold
14.29%
Sell
Based on 14 analysts, 78.57% of analysts recommend a 'BUY' rating for Harmony Biosciences Holdings Inc. Average target price of $44.55
Get share price movements and forecasts by analysts on Harmony Biosciences Holdings Inc.
What analysts predicted
29.45%UPSIDE
Target Price
$44.55
Current Price
$31.43
Analyzed by
14 Analysts
Target
$44.55
Harmony Biosciences Holdings Inc target price $44.55, a slight upside of 29.45% compared to current price of $31.43. According to 14 analysts rating.
Search interest for Harmony Biosciences Holdings Inc Stock has increased by 6% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:6% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 184.73M → 239.45M (in $), with an average increase of 12.1% per quarter
Price Rise
![]()
In the last 7 days, HRMY stock has moved up by 8.3%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 39.77M → 50.86M (in $), with an average increase of 21.8% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 152.5% return, outperforming this stock by 166.7%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 897.2% return, outperforming this stock by 944.4%
| Organisation | Harmony Biosciences Holdings Inc |
| Headquarters | 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462 |
| Industry | Health Technology |
| CEO | Dr. Jeffrey M. Dayno M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Sandip S. Kapadia CPA, M.B.A. | Executive VP, Chief Administrative Officer & CFO |
Brennan Doyle | VP & Head of Investor Relations |
Ms. Tricia Glover | Chief Compliance Officer |
Mr. Christian Ulrich J.D. | General Counsel & Corporate Secretary |
Ms. Audrey Murphy SPHR | Chief Human Resources Officer |
Ms. Cate McCanless | Senior VP & Chief Corporate Affairs Officer |
Mr. Jeffrey S. Aronin | Founder & Non-Executive Chairman |
Dr. Jeffrey M. Dayno M.D. | President, CEO & Director |
Dr. Kumar Budur M.D., M.S. | Executive VP and Chief Medical & Scientific Officer |
Mr. Andrew Serafin J.D., M.B.A. | Executive VP & Chief Strategy Officer |
Harmony Biosciences Holdings Inc share price today is $31.43 as on at the close of the market. Harmony Biosciences Holdings Inc share today touched a day high of $31.84 and a low of $30.56.
Harmony Biosciences Holdings Inc share touched a 52 week high of $40.93 on and a 52 week low of $25.52 on . Harmony Biosciences Holdings Inc stock price today i.e. is closed at $31.43,which is 23.21% down from its 52 week high and 23.16% up from its 52 week low.
Harmony Biosciences Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Harmony Biosciences Holdings Inc (HRMY) shares with as little as ₹88.66 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.60 in Harmony Biosciences Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Harmony Biosciences Holdings Inc share’s latest price of $31.43 as on November 8, 2025 at 2:29 am IST, you will get 0.3182 shares of Harmony Biosciences Holdings Inc. Learn more about
fractional shares .
Harmony Biosciences Holdings Inc stock has given -31.15% share price returns and 19.94% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?